Prevalence of age-related macular degeneration in Portugal: The Coimbra eye study - Report 1

Ophthalmologica

Volumn 233, Issue , 2015, Pages 119-127

  Cachulo, Maria Da Luz ^a,b   Lobo, Conceição ^a,b,c   Figueira, João ^a,b   Ribeiro, Luisa ^b   Laíns, Inês ^a   Vieira, António ^f   Nunes, Sandrina ^b   Costa, Miguel ^b   Simão, Sílvia ^b   Rodrigues, Victor ^d   Vilhena, Nelson ^e   Cunha Vaz, José ^b   Silva, Rufino ^a,b,c  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

^c Faculty of Medicine   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e Critical Health   (Portugal)

^f Primary Health Care Center   (Portugal)

Author keywords

Age related macular degeneration; Geographic atrophy; Neovascular age related macular degeneration

Indexed keywords

ADULT; AGE; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CONTROLLED STUDY; EYE EXAMINATION; FEMALE; GENDER; GEOGRAPHIC ATROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PORTUGAL; PREVALENCE; SMOKING; VERY ELDERLY; AGE DISTRIBUTION; CLASSIFICATION; CROSS-SECTIONAL STUDY; PHOTOGRAPHY; SEX RATIO; WET MACULAR DEGENERATION;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GEOGRAPHIC ATROPHY; HUMANS; MALE; MIDDLE AGED; PHOTOGRAPHY; PORTUGAL; PREVALENCE; SEX DISTRIBUTION; WET MACULAR DEGENERATION;

EID: 84930929852     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000371584     Document Type: Article

References (43)

1. Tomany SC, et al: Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004; 111: 1280-1287.
2. Bird AC, et al: An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-374.
3. Klein R, et al: The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98: 1128-1134.
4. Age-Related Eye Disease Study Research Group: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol 2001; 119: 1417-1436.
5. Liu MM, Chan CC, Tuo J: Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics 2012; 6: 13.
6. Smith W, et al: Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001; 108: 697-704.
7. Klein R: Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol 2007; 14: 184-187.
8. Hogg RE, et al: Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008; 115: 1046-1052.e2.
9. Snow KK, Seddon JM: Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 1999; 6: 125-143.
10. Friedman DS, et al: Racial differences in the prevalence of age-related macular degeneration: The Baltimore Eye Survey. Ophthalmology 1999; 106: 1049-1055.
11. Klein R, Klein BE, Linton KL: Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933-943.
12. Bressler SB, et al: Racial differences in the prevalence of age-related macular degeneration: The Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol 2008; 126: 241-245.
13. Klein R, et al: Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 1999; 117: 1203-1210.
14. Klein R, et al: Early age-related maculopathy in the cardiovascular health study. Ophthalmology 2003; 110: 25-33.
15. Klein R, et al: Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006; 113: 373-380.
16. Mitchell P, et al: Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450-1460.
17. VanNewkirk MR, et al: The prevalence of agerelated maculopathy: The visual impairment project. Ophthalmology 2000; 107: 1593-1600.
18. Vingerling JR, et al: The prevalence of agerelated maculopathy in the Rotterdam Study. Ophthalmology 1995; 102: 205-210.
19. Augood CA, et al: Prevalence of age-related maculopathy in older Europeans: The European Eye Study (EUREYE). Arch Ophthalmol 2006; 124: 529-535.
20. Topouzis F, et al: Prevalence of age-related macular degeneration in Greece: The Thessaloniki Eye Study. Am J Ophthalmol 2006; 142: 1076-1079.
21. Jonasson F, et al: The prevalence of age-related maculopathy in Iceland: Reykjavik Eye Study. Arch Ophthalmol 2003; 121: 379-385.
22. Delcourt C, et al: Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol 1998; 116: 1031-1035.
23. Delcourt C, et al: Nutrition and age-related eye diseases: The Alienor (Antioxydants, Lipides Essentiels, Nutrition et maladies Oculai-Res) Study. J Nutr Health Aging 2010; 14: 854-861.
24. Friedman DS, et al: Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122: 564-572.
25. Li Y, et al: Prevalence of age-related maculopathy in the adult population in China: The Beijing Eye Study. Am J Ophthalmol 2008; 146: 329.
26. Chen SJ, et al: Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: The Shihpai Eye Study. Invest Ophthalmol Vis Sci 2008; 49: 3126-3133.
27. Erke MG, et al: Prevalence of age-related macular degeneration in elderly Caucasians: The Tromso Eye Study. Ophthalmology 2012; 119: 1737-1743.
28. Piermarocchi S, et al: The prevalence of agerelated macular degeneration in Italy (PAMDI) study: report 1. Ophthalmic Epidemiol 2011; 18: 129-136.
29. Davis MD, et al: The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 2005; 123: 1484-1498.
30. Ferris FL, et al: A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005; 123: 1570-1574.
31. Seddon JM, Sharma S, Adelman RA: Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 2006; 113: 260-266.
32. Ferris FL 3rd, et al: Clinical classification of age-related macular degeneration. Ophthalmology 2013; 120: 844-851.
33. Marques JP, et al: Ocular risk factors for exudative AMD: A novel semiautomated grading system. ISRN Ophthalmol 2013; 2013: 464218.
34. Jonasson F, et al: Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study. Ophthalmology 2011; 118: 825-830.
35. van Leeuwen R, et al: The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam Study. Arch Ophthalmol 2003; 121: 519-526.
36. Pagliarini S, et al: Age-related macular disease in rural southern Italy. Arch Ophthalmol 1997; 115: 616-622.
37. Rudnicka AR, et al: Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: A meta-analysis. Ophthalmology 2012; 119: 571-580.
38. Thornton J, et al: Smoking and age-related macular degeneration: A review of association. Eye (Lond) 2005; 19: 935-944.
39. Chakravarthy U, et al: Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 2007; 114: 1157-1163.
40. Khan JC, et al: Smoking and age related macular degeneration: The number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 2006; 90: 75-80.
41. Tan JS, et al: Smoking and the long-term incidence of age-related macular degeneration: The Blue Mountains Eye Study. Arch Ophthalmol 2007; 125: 1089-1095.
42. Mitchell P, et al: Smoking and the 5-year incidence of age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol 2002; 120: 1357-1363.
43. Klein R, et al: Ten-year incidence of age-related maculopathy and smoking and drinking: The Beaver Dam Eye Study. Am J Epidemiol 2002; 156: 589-598.